BIONOVIS S.A. - COMPANHIA BRASILEIRA DE BIOTECNOLOGIA FARMACEUTICA won AQUISIÇÃO DE RITUXIMABE, NAKED VIAL; 500 MG; 50ML; 43005901, SANDOZ; CX 50 FR from INSTITUTO DE TECNOLOGIA EM IMUNOBIOLOGICOS

INSTITUTO DE TECNOLOGIA EM IMUNOBIOLOGICOS · Brazil government award

GlobalGov surfaces government contract awards from around the world, including the markets your competitors overlook.

$10.8M
Award Value
June 18, 2026
Award Date
Awarded
Status

Award Overview

BIONOVIS S.A. - COMPANHIA BRASILEIRA DE BIOTECNOLOGIA FARMACEUTICA was awarded AQUISIÇÃO DE RITUXIMABE, NAKED VIAL; 500 MG; 50ML; 43005901, SANDOZ; CX 50 FR by INSTITUTO DE TECNOLOGIA EM IMUNOBIOLOGICOS in Brazil, tracked by GlobalGov. The award is valued at $10.8M. It was awarded on June 18, 2026. Full award details and the issuing agency are below.

See who is winning government contracts in this market — and the open opportunities coming next. Track awards, incumbents, and recompetes worldwide. Free for 14 days, no card.

Start Free

Award Details

AwardeeBIONOVIS S.A. - COMPANHIA BRASILEIRA DE BIOTECNOLOGIA FARMACEUTICA
Awardee countryBrazil
Awarding agencyINSTITUTO DE TECNOLOGIA EM IMUNOBIOLOGICOS
CountryBrazil
Award value$10.8M
Award dateJune 18, 2026
Official sourceView original award record
Last verifiedSeptember 1, 2026

Source: Compras.gov.br, Government of Brazil — open data under Lei 12.527/2011 and Decreto 8.777/2016. Not affiliated with the Government of Brazil.

Track every Brazil contract award and the opportunities behind them. Free for 14 days.

Get incumbent intelligence, recompete alerts, and deadline tracking for this market and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required